Growth Hormone Secretagogues: A Research Overview

Research Use Only. The information below summarizes preclinical and pharmacological literature for laboratory and educational reference. It is not for human or veterinary use, and nothing here should be read as medical guidance, dosing information, or a health claim.

"Growth hormone secretagogue" is an umbrella term for a group of research compounds that share one common feature in the scientific literature: in model systems they influence the pathways that regulate the release of growth hormone from the anterior pituitary. The category is a useful lens for researchers because it links several compounds that are otherwise studied separately, including the growth hormone releasing peptides (GHRPs), the growth hormone releasing hormone (GHRH) analogs, and the small orally active molecule MK-677. This overview maps how these subgroups sit next to one another in the research record and how they differ at the receptor level.

What is a growth hormone secretagogue

A secretagogue is simply a substance that, in a biological model, promotes secretion of something else. In this category, the "something else" is growth hormone (GH). The term covers two mechanistically distinct receptor systems plus their synthetic ligands. The first is the ghrelin receptor, formally the growth hormone secretagogue receptor type 1a (GHS-R1a), and the second is the GHRH receptor. Compounds are grouped together not because they are chemically similar but because their downstream readout in laboratory studies overlaps.

Because the naming is inconsistent in older literature, it helps to separate the compounds by which receptor they engage rather than by trade or research nicknames. That is the structure used throughout this page.

Where these compounds sit in the research literature

The subgroups below are all represented in the Pure Chems research catalog and each has its own dedicated research overview. This page is the cluster hub that ties them together.

Reported subgroups studied in preclinical work

• GHRP peptides (ghrelin receptor ligands): compounds such as GHRP-2 and GHRP-6 are studied as synthetic agonists of GHS-R1a, the same receptor targeted by the natural peptide ghrelin.
• Selective ghrelin-receptor research peptides: Ipamorelin is frequently described in the literature as a more selective GHS-R1a ligand used to probe the pathway with fewer off-target readouts.
• GHRH analogs: Sermorelin and Tesamorelin are studied as analogs of growth hormone releasing hormone, acting at the separate GHRH receptor rather than the ghrelin receptor.
• Non-peptide oral secretagogues: MK-677 (Ibutamoren) is an orally active small molecule investigated as a long-acting GHS-R1a ligand, distinct from the injectable peptides.
• Combination research models: the Ipamorelin and CJC-1295 combination is examined in the literature because it pairs a ghrelin-receptor ligand with a GHRH analog, letting researchers study the two receptor systems side by side.

Chemistry and notes at a glance

The peptide members of this group (GHRP-2, GHRP-6, Ipamorelin, Sermorelin, Tesamorelin) are short synthetic peptides supplied as lyophilized powder, while MK-677 is a non-peptide small molecule. Key points a researcher typically records include the molecular identity and sequence for peptides, molecular weight, purity as verified by HPLC, and the certificate of analysis (COA) for a given batch. Because the peptides and the small molecule have very different stability profiles, storage handling is documented separately for each rather than assumed to be identical.

Why the "research use only" label matters

In the European Union these compounds are supplied as chemical reagents for laboratory research under the REACH framework, not as medicines. That classification depends entirely on how a product is presented. The moment a listing attaches a therapeutic claim or implies human or veterinary use, it can fall under EU medicinal-product law (Directive 2001/83/EC). For that reason the material on this site describes only in vitro, animal, and mechanistic findings in the third person and never provides human dosing, administration, or usage protocols.

Regulatory and safety note: growth hormone secretagogues, including GHRPs, GHRH analogs, and MK-677, are prohibited in sport at all times under the World Anti-Doping Agency (WADA) Prohibited List (class S2, peptide hormones and growth factors and their releasing factors). They are research compounds and are not approved as general-use medicines in the EU. This note is informational and is not usage guidance.

Handling and storage for researchers

General laboratory practice reported for lyophilized research peptides is to keep the sealed vials cold and protected from light, with long-term storage typically at freezer temperatures and short-term handling at refrigerated temperatures. Reconstitution for in vitro work is usually carried out with an appropriate research diluent such as bacteriostatic water or, for certain peptides, a dilute acetic acid solution, after which reconstituted material is generally kept refrigerated and used within a documented window. MK-677, as a small molecule, follows its own stability profile rather than the peptide handling notes. These are laboratory storage observations, not preparation instructions for any applied use.

Frequently asked questions

What does "growth hormone secretagogue" actually mean?

It is a functional label for compounds that, in laboratory models, act on the ghrelin receptor (GHS-R1a) or the GHRH receptor, both of which sit upstream of growth hormone release. It describes a shared readout in research, not a single chemical class.

Are GHRPs and GHRH analogs the same thing?

No. GHRPs such as GHRP-2 and GHRP-6 are ligands of the ghrelin receptor, while GHRH analogs such as Sermorelin and Tesamorelin act at the distinct GHRH receptor. They are often discussed together because their studied endpoints overlap, but the receptor biology differs.

Are these compounds approved medicines?

As a group they are handled as research chemicals, not general-use approved medicines, in the EU. Some individual molecules have been the subject of clinical investigation in specific contexts, but that does not make the research-grade material a medicine. They are supplied strictly for research use only.

Is it legal to buy growth hormone secretagogues for research in the EU?

Within the EU these are generally available as laboratory reagents for research use only under the REACH chemical framework, provided they are not marketed or used for human or veterinary purposes. Researchers remain responsible for compliance with national rules in their own country.

Why do these appear on the WADA Prohibited List?

Because they influence pathways connected to growth hormone release, WADA lists this category under S2 as prohibited in sport at all times. This is a regulatory status point relevant to researchers documenting a compound, not an endorsement of any use.

Key takeaways

• Growth hormone secretagogue is a functional umbrella covering ghrelin-receptor ligands (GHRPs, Ipamorelin, MK-677) and GHRH-receptor analogs (Sermorelin, Tesamorelin).
• The two receptor systems, GHS-R1a and the GHRH receptor, are distinct, which is why the subgroups are studied separately even when their endpoints overlap.
• All of this material is supplied for research use only, with no human or veterinary use implied, and the category is WADA-prohibited in sport.
• Each compound has its own dedicated research overview and its own handling notes; this page is the cluster hub linking them.

References

References sourced via PubMed.

1. Yanagi S, Sato T, Kangawa K, Nakazato M. The Homeostatic Force of Ghrelin. Cell Metabolism. 2018. https://doi.org/10.1016/j.cmet.2018.02.008 | https://pubmed.ncbi.nlm.nih.gov/29576534/
2. Noh JY, Herrera M, Patil BS, Tan XD, Wright GA, Sun Y. The expression and function of growth hormone secretagogue receptor in immune cells: A current perspective. Experimental Biology and Medicine. 2022. https://doi.org/10.1177/15353702221121635 | https://pubmed.ncbi.nlm.nih.gov/36151745/

Disclaimer: All products and information are provided for research use only and are not intended for human or veterinary use. Nothing on this page is medical advice, a therapeutic claim, or a recommendation for any use in humans or animals. Compounds discussed are laboratory reagents to be handled only by qualified researchers.

Explore the related research material: MK-677 research overview, and browse growth hormone secretagogue reference peptides such as Ipamorelin in the Pure Chems catalog.